1. HBW Insight
  2. >>Archive

P&G’s NIOXIN Shows How To Address Hair Loss Without An FDA Warning

 
• By Ryan Nelson

With FDA scrutinizing the marketplace for cosmetics promoted as drugs, and a clear cautionary statement from the agency about topical products marketed as hair growers or hair-loss preventers, beauty firms have little choice but to incorporate approved OTC drug ingredients in such products. P&G’s professional hair-care brand NIOXIN has done just that with its new Advanced Thinning range featuring minoxidil.

Procter & Gamble Co.’s NIOXIN professional hair-care unit launches Advanced Thinning products, demonstrating how adoption of FDA-approved over-the-counter drug ingredients can enable companies to address aging hair complaints without risk of inviting regulatory enforcement action.

Acquired by P&G in 2008, NIOXIN uses advanced technologies to address the needs of men and women experiencing thinning hair, “whether in the form of excessive shedding or breakage,” which affects more than 75%

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from HBW Insight